Favipiravir is more economical, says Glenmark to DCGI

Glenmark Pharma has come under the scanner of DCGI which sought clarifications from the company on pricing and claims of therapeutic efficacy.

from The Financial Express https://ift.tt/2OLL3Bq
https://ift.tt/eA8V8J FE Bureau